Mesoblast limited (ASX:MSB)
share price: (EoD)
earnings per share:
dividends per share:
Mesoblast Limited (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
Mesoblast limited (ASX:MSB) share price
Mesoblast limited (ASX:MSB) passive income
Mesoblast limited (ASX:MSB) share price news
S&P/ASX 200 morning report – CBA, MSB & ORI shares in focus
The S&P/ASX 200 (INDEXASX:XJO) is tipped to open higher on Monday. Commonwealth Bank (ASX:CBA) and Mesoblast (ASX:MSB) shares are in the news.
Why the Mesoblast (ASX:MSB) share price is going nuts
The Mesoblast Limited (ASX:MSB) share price is going nuts this morning after announcing a deal with Novartis (SWX:NOVN).
Why the Mesoblast (ASX:MSB) share price is surging
The Mesoblast Limited (ASX:MSB) share price is surging this morning after making an announcement about its COVID-19 trial.
Should you buy the Mesoblast (ASX:MSB) share price dip?
It has been an absolute rollercoaster ride for anyone who holds shares in Mesoblast Limited (ASX: MSB) this year. Is it time to buy in?
Novonix (ASX:NVX) shares are interesting… but a hold at best
Novonix Ltd (ASX:NVX) was the most-traded stock on the ASX last week, overtaking some of the more well-known names such as Brainchip (ASX:BRN) and Zip Co (ASX:Z1P).
Mesoblast (ASX:MSB) share price plunges on FDA decision
The Mesoblast Limited (ASX:MSB) share price could suffer after the FDA’s decision about remestemcel-L.
Why the Mesoblast (ASX:MSB) share price is up 6%
The Mesoblast Limited (ASX:MSB) share price is up more than 6% after announcing that it has won an award.
Mesoblast’s (ASX:MSB) good COVID-19 news
Mesoblast Limited (ASX:MSB) shares dropped 3% on Friday after announcing news relating to COVID-19 patients.
Mesoblast (ASX:MSB) share price rockets higher
The Mesoblast Limited (ASX:MSB) share price has soared 38% higher after the biotech business announced positive US news.